There are two types of denial of access. There are drug shortages, which people know of all the time. These are products that people are used to taking, and for different reasons they are not available in the market. The second part is products that are approved in other markets and brand companies aren't bringing them into Canada.
On February 7th, 2019. See this statement in context.